Phytomedicine and Alzheimer's Disorder

 
 
CRC Press
  • erscheint ca. am 30. Dezember 2020
 
  • Buch
  • |
  • Hardcover
  • |
  • 586 Seiten
978-0-367-33202-0 (ISBN)
 
Alzheimer's disease, one of the most rapidly growing neurodegenerative disorders, is characterized by progressive loss of memory. Despite several advancements in the field of medicinal therapeutics, a viable treatment for Alzheimer's disease is the need of great importance. Medicinal plants represent a great deal of untapped reservoir of natural medicines and potential source of anti-Alzheimer's drug. The structural diversity of their phytoconstituents makes them a valuable source of novel lead compounds for the quest of drugs to treat Alzheimer's disease. Based on the traditional literature, various new therapeutically active compounds have been isolated from phytoextracts useful in cognitive disorders.





The book "Phytomedicine and Alzheimer's disorder" presents information on











Mechanistic aspects of neurodegeneration in Alzheimer's disease and role of phytochemicals as restorative agents







Helps in understanding the complex biochemical aspects of Alzheimer's disorder







Pre-clinical approaches to evaluate drugs targeting Alzheimer's disease







Aternative approach to encounter Alzheimer's disease and role of alternative medicine to delay the symptomatic progression of the same







Epigenetic alterations in Alzheimer's disease and its therapeutic, dietary interventions








This book serves as an excellent resource for scientific investigators, academician, biochemists, botanists, alternative medicine practitioners who are intended to emphasize the role of phytomedicines to treat Alzheimer's disease.
  • Englisch
  • London
  • |
  • Großbritannien
Taylor & Francis Ltd
  • Für höhere Schule und Studium
27 Tables, black and white; 15 Illustrations, color; 33 Illustrations, black and white
  • Höhe: 254 mm
  • |
  • Breite: 178 mm
978-0-367-33202-0 (9780367332020)

Dr. Atanu Bhattacharjee, M.Pharma, Ph.D. is currently working as Associate Professor in Faculty of Pharmaceutical science, Assam Down Town University, Assam, India. His area of specialization includes Pharmacognosy & Phytochemistry. Dr. Bhattacharjee holds a master's degree in Pharmacognosy from J.S.S. College of Pharmacy, Ooty India. He was the recipient of Senior Research Fellow (CCRAS, New Delhi). He has obtained his Ph.D in Pharmaceutical Sciences from Nitte University, Mangalore (NAAC 'A' graded University) in 2015 in the area of phytochemistry and neuropharmacology of traditional Indian medicinal plant. He worked extensively on evaluation of nootropic potential of Ayurvedic plant with emphasizing their effect on cholinergic neurotransmission. His research contribution includes assessment of several in-vivo neuro-pharmacological assay and in-vitro cholinesterase enzyme, antioxidant potential of drugs obtained from natural sources. He is the Honorable Academic Editor of Asian Journal of Medicine and Health, SCIENCEDOMAIN International, India. He is also the Associate Editor of MedCrave Online Journal of Tumor Research. Recently he has been elected as Editorial Board member of Integrative Trauma and Emergency Medicine. He is registered Ph.D guide of Assam down town University. More than 20 research and review articles in reputed national/international journals were added to his credit. He has authored many book chapters in various reputed International Publishers Taylor & Francis and Springer, USA. He presented several scientific papers, attended a number of national and international conferences and delivered invitee lecture in different scientific forums. He is a life time member of Indian Pharmaceutical Association, Mumbai, India. At present, he is Editorial team member of 07 and reviewer of more than 10 highly reputed International Journals. He is involved enthusiastically in scientific research on traditional medharasayana drugs and to develop active research culture.


Dr. Ramakrishna Akula is currently a scientist at Bayer Crop Science, Bangalore, India. Dr. Ramakrishna holds a master's degree from Sri Krishna Devaraya University, Anantapur, Andhra Pradesh, India. He obtained his Ph.D. in biochemistry from University of Mysore, CSIR-CFTRI, Mysuru. He is a Senior Research Fellow of CSIR, New Delhi. He is involved in various research fields such as Plant Biotechnology, Biochemistry, Plant secondary metabolites, Food Science and Technology and Vegetable quality analytics. He has published several research papers in the leading international journals, published 3 books, reviews and book chapters. He is also serving as editorial board member, and reviewer for reputed international journals. Presented over 20 research papers in symposia in India and abroad, as well as few invited lectures in India. He attended the Fifth International Symposium on Plant Neurobiology held in 2009 in Florence, Italy. He also attended the Technical Community of Monsanto (TCM) held in 2016, in St. Louis, Missouri. He is a member of the Indian science congress association and society for biotechnologists (India). He is a fellow of the Society for Applied Biotechnology, India (2012), and recipient of Global Vegetable Research Excellence Award (2017), Global technology recognition, Rapid Recognition Award, and Special recognition from the Monsanto company.


Obulesu Magisetty is currently a scientist at ATG Laboratories, Pune, India. He has 18 years of research and teaching experience. His research areas are multifarious which include food science, pathology of Neurodegenerative diseases such as Alzheimer's disease and designing polymer based Biomaterials (Design of hydrogels etc.). He did Alzheimer's disease research and developed an aluminium induced neurotoxicity rabbit model. His present research focuses on development of redox-active injectable hydrogels of polyion complex. His research area also includes development of metal chelators to overcome metal induced toxicity. His books, a monograph entitled "Alzheimer's Disease Theranostics (Elsevier (First Edition))" and an editorial collection "Alternative Medicine for Alzheimer's Disease (Taylor and Francis)" are in progress currently (Proposals accepted and Work in Progress). He is the first and corresponding author for majority of his articles. He secured a certificate from Stanford University for the Scientific Writing course. He is on editorial board of a few pathology journals such as Journal of Medical Laboratory and Diagnosis, Journal of Medical and Surgical Pathology, Annals of Retrovirals and Antiretrovirals, Kenkyu Journal of Medical Science and Clinical Research, SciFed Oncology and Cancer Research Journal, Journal of Cancer and Cure. He is also on editorial board of nanotechnology journals such as SciFed Nanotech Research Letters, SciFed Drug Delivery Research, Current Updates in Nanotechnology and Journal of Nanotechnology and Materials Science.
Annonaceae species: A perspective for developing phytomedicines for Alzheimer's disease
Chistiane Mendes Feitosa, Antonia Laires da Silva Santos, Alyandra de Sousa Nascimento, Veruska Cavalcanti Barros, Valeria Lima Silva Veras, and Mahendra Rai


An alternative approach for anti-Alzheimer's compounds from plant isolates
Pratap G.K. and Manjula Shantaram


Phytotherapeutic potential for the treatment of Alzheimer disease
Muhammad Akram, Atanu Bhattacharjee, Naveed Munir, Naheed Akhter, Fozia Anjum, Abida Parveen, Samreen Gul Khan, Muhammad Daniyal, Muhammad Riaz, Fahad Said Khan, Rumaisa Ansari, and Umme Laila


Cognitive improvement, Neuroprotective and Nootropic Effect of Medhya Rasayana Drugs in Alzheimer's Disease
Rinki Kumari, Jasmeet Singh, Bhargawi Mishra, Anamika Tiwari, and Abaid Nath Singh


Prevention and treatment of Alzheimer's disease in the light of Ayurveda
Vinayak Majhi, Bishnu Choudhury, and Sudip Paul


Medharasayana plant: an Ayurvedic approach to Alzheimer's disease
Atanu Bhattacharjee and Biplab kumar Dey


Ethomedicinal plants used by the tribes of northeast India to treat Alzheimer's disease
B. R. Sarkar


Neuroprotective Role of Resveratrol in Alzheimer's Disease
V.S. Dendi and Magisetty Obulesu


Pre-clinical in-vivo and in-vitro methods for evaluation of anti-Alzheimer's drugs
Shilpa A. Deshpande and Niraj S. Vyawahare


Antioxidant Phytochemicals and Alzheimer's Disorder: Current Understanding and Future Scope
Saikat Sen, Raja Chakraborty, and Atanu Bhattacharjee


Neuroprotective role of Curcumin in Alzheimer's Disease
Magisetty Obulesu and Mahendran B


Epigenetic Alterations in Alzheimer's Disease and its therapeutic and dietary interventions
Aswathy PM, Shafeeque CM, and Moinak Banerjee


Mechanistic aspects of Neurodegeneration in Alzheimer's Disease and role of phytochemicals as restorative agents
Anindita Kundu, Vivekananda Mandal, Sujata Wangkheirakpam, and Subhash C. Mandal


Pre-clinical approaches and methods on Alzheimer's: in-vivo and in-vitro
S.R.Chandra and Pooja Mailankody


Ethanolic extracts of Dysphania ambrosioides alleviates scopolamine-induced amnesia in experimental animals
Rajashri Bezbaruah, Chandana C. Barua, Lipika Buragohain, Pobitra Borah, Iswar Chandra Barua and Ghanshyam Panigrahi


Neuroprotective Role of Quercetin in Alzheimer's Disease
Magisetty Obulesu


Plant Alkaloids and their derivatives relevant to Alzheimer's disease
Atanu Bhattacharjee and Ramakrishna Akula


Epigallocatechin -3-Gallate in Alzheimer's Disease
Khaleel Pasha Md, Magisetty Obulesu


-secretase (BACE-1) inhibitors from natural product: a novel therapeutic approach to encounter Alzheimer's disorder
Atanu Bhattacharjee


Carotenoids and Alzheimer's Disease
Magisetty Obulesu

Noch nicht erschienen

163,71 €
inkl. 7% MwSt.
Vorbestellen